Titill: | Elevated symptoms of depression and anxiety among family members and friends of critically ill COVID-19 patients – an observational study of five cohorts across four countries |
Höfundur: |
... 17 fleiri höfundar Sýna alla höfunda |
Útgáfa: | 2023-10 |
Tungumál: | Enska |
Umfang: | 1590082 |
Háskóli/Stofnun: | Landspitali - The National University Hospital of Iceland |
Deild: | Interdisciplinary Graduate Studies Faculty of Medicine |
Birtist í: | The Lancet Regional Health - Europe; 33() |
ISSN: | 2666-7762 |
DOI: | 10.1016/j.lanepe.2023.100733 |
Efnisorð: | Sálfræði; Anxiety; COVID-19; Cross-country study; Depression; Significant person; Internal Medicine; Oncology; Health Policy |
URI: | https://hdl.handle.net/20.500.11815/4556 |
Tilvitnun:Lovik , A , González-Hijón , J , Hoffart , A , Fawns-Ritchie , C , Magnúsdóttir , I , Lu , L , Unnarsdóttir , A B , Kähler , A K , Campbell , A , Hauksdóttir , A , Chourpiliadis , C , McCartney , D L , Thordardóttir , E B , Joyce , E E , Frans , E M , Jakobsdóttir , J , Trogstad , L , Andreassen , O A , Magnus , P , Johnson , S U , Sullivan , P F , Aspelund , T , Porteous , D J , Ask , H , Ebrahimi , O V , Valdimarsdóttir , U A & Fang , F 2023 , ' Elevated symptoms of depression and anxiety among family members and friends of critically ill COVID-19 patients – an observational study of five cohorts across four countries ' , The Lancet Regional Health - Europe , vol. 33 , 100733 , pp. 100733 . https://doi.org/10.1016/j.lanepe.2023.100733
|
|
Útdráttur:Background: Little is known regarding the mental health impact of having a significant person (family member and/or close friend) with COVID-19 of different severity. Methods: The study included five prospective cohorts from four countries (Iceland, Norway, Sweden, and the UK) with self-reported data on COVID-19 and symptoms of depression and anxiety during March 2020–March 2022. We calculated prevalence ratios (PR) of depression and anxiety in relation to having a significant person with COVID-19 and performed a longitudinal analysis in the Swedish cohort to describe temporal patterns. Findings: 162,237 and 168,783 individuals were included in the analysis of depression and anxiety, respectively, of whom 24,718 and 27,003 reported a significant person with COVID-19. Overall, the PR was 1.07 (95% CI: 1.05–1.10) for depression and 1.08 (95% CI: 1.03–1.13) for anxiety in relation to having a significant person with COVID-19. The respective PRs for depression and anxiety were 1.15 (95% CI: 1.08–1.23) and 1.24 (95% CI: 1.14–1.34) if the patient was hospitalized, 1.42 (95% CI: 1.27–1.57) and 1.45 (95% CI: 1.31–1.60) if the patient was ICU-admitted, and 1.34 (95% CI: 1.22–1.46) and 1.36 (95% CI: 1.22–1.51) if the patient died. Individuals with a significant person with hospitalized, ICU-admitted, or fatal COVID-19 showed elevated prevalence of depression and anxiety during the entire year after the COVID-19 diagnosis. Interpretation: Family members and close friends of critically ill COVID-19 patients show persistently elevated prevalence of depressive and anxiety symptoms. Funding: This study was primarily supported by NordForsk (COVIDMENT, 105668) and Horizon 2020 (CoMorMent, 847776).
|
|
Athugasemdir:Publisher Copyright: © 2023 The Author(s)
|